{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:02:46Z","timestamp":1756339366760,"version":"3.44.0"},"reference-count":24,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2023,3,1]]},"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:p>Peppermint oil capsules are prescribed to manage abdominal colic and distension, a common complaint in postcaesarean section patients. Arachis (peanut) oil is contained within one frequently prescribed peppermint formulation: Colpermin. This ingredient is contraindicated in patients with peanut and soya allergy; however, this is not stated in the side effects or contraindications section of the British National Formulary, or present on the medication packaging. A postpartum woman in her early 30s had an unexpected allergic reaction to the capsules, in the form of a generalised body rash, fortunately with no anaphylactic features. The patient reported the same reaction to soya in the past. After review of the patient\u2019s clinical and medication history, Colpermin capsules were thought to be responsible for the patient\u2019s symptoms. This case highlights the necessity for clearer documentation in prescribing formularies and on medication packaging to ensure patient safety.<\/jats:p>","DOI":"10.1136\/bcr-2022-252602","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T10:20:31Z","timestamp":1678789231000},"page":"e252602","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["An unexpected allergic skin reaction to peppermint oil capsules"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8505-1840","authenticated-orcid":false,"given":"Gabrielle","family":"Sanders","sequence":"first","affiliation":[{"name":"Obstetrics and Gynaecology, Colchester Hospital, East Suffolk and North Essex NHS Foundation Trust, Colchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,3,14]]},"reference":[{"key":"2025082701124557000_16.3.e252602.1","unstructured":"District general hospital pharmacy annual colpermin stock [private online database]. 2022."},{"key":"2025082701124557000_16.3.e252602.2","unstructured":"Medicines.org.uk . Colpermin IBS Relief Capsules [Internet]. Summary of Product Characteristics (SmPC) - (emc). 2021. Available: www.medicines.org.uk\/emc\/product\/1076\/smpc"},{"key":"2025082701124557000_16.3.e252602.3","unstructured":"Bnf.nice.org.uk . Medicinal forms | Peppermint oil | Drugs. [Internet].National Institute for Health and Care Excellence. 2022. Available: https:\/\/bnf.nice.org.uk\/medicinal-forms\/peppermint-oil.html"},{"key":"2025082701124557000_16.3.e252602.4","unstructured":"McNeil Products Ltd . Colpermin IBS relief capsules [Internet]. High Wycombe: McNeil Products Limited. 2021. Available: www.medicines.org.uk\/emc\/files\/pil.1076.pdf"},{"key":"2025082701124557000_16.3.e252602.5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/cea.12957","article-title":"BSACI guideline for the diagnosis and management of peanut and tree nut allergy","volume":"47","author":"Stiefel","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"2025082701124557000_16.3.e252602.6","unstructured":"Nice.org.uk . Introduction | Anaphylaxis: assessment and referral after emergency treatment | Guidance [Internet]; National Institute for Health and Care Excellence. 2020. Available: www.nice.org.uk\/guidance\/cg134\/chapter\/Introduction"},{"key":"2025082701124557000_16.3.e252602.7","unstructured":"UK Medicines information . What issues should be considered in patients with peanut allergy requiring a medicine containing soya?. [Internet] Southampton: NHS Specialist pharmacy service, Pp 2-3. 2020. Available: www.sps.nhs.uk\/wp-content\/uploads\/2020\/10\/UKMi-QA_Peanut_and_soya_allergy_April-2020.pdf"},{"key":"2025082701124557000_16.3.e252602.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.02.001"},{"key":"2025082701124557000_16.3.e252602.9","doi-asserted-by":"crossref","DOI":"10.1136\/adc.2007.120949","article-title":"Did you know this medicine has peanut butter in it, doctor?","volume":"92","author":"Dixon","year":"2007","journal-title":"Arch Dis Child"},{"key":"2025082701124557000_16.3.e252602.10","unstructured":"Wragg J , Swann E . Case study: an error with a medicine containing arachis oil[internet]. the pharmaceutical journal; the royal pharmaceutical society. 2022. Available: https:\/\/pharmaceutical-journal.com\/article\/ld\/case-study-an-error-with-a-medicine-containing-arachis-oil"},{"key":"2025082701124557000_16.3.e252602.11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1017\/S0022215107000138","article-title":"Naseptin and peanut oil: a survey of practitioners\u2019 awareness in the UK","volume":"122","author":"Abed","year":"2008","journal-title":"J Laryngol Otol"},{"key":"2025082701124557000_16.3.e252602.12","unstructured":"Committee on the Safety of Medicines . Medicines containing peanut (arachis) oil. current problems in pharmacovigilance. 2003. Available: http:\/\/webarchive.nationalarchives.gov.uk\/20141205150130\/www.mhra.gov.uk\/home\/groups\/pl-p\/documents\/websiteresources\/con007450.pdf"},{"key":"2025082701124557000_16.3.e252602.13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.1998.00325.x"},{"key":"2025082701124557000_16.3.e252602.14","unstructured":"Dornan T , Ashcroft D , Heathfield H , et al . An in-depth investigation into causes of prescribing errors by foundation trainees in relation to their medical education: EQUIP study. General Medical Council 2009;61\u201369."},{"key":"2025082701124557000_16.3.e252602.15","unstructured":"Leemans L , Heylen N , Quanten A , et al . Etude sur l\u2019utilisation des notices destin\u00e9es aux patients [consumer study on the use of patient information leaflets]. J Pharm Belg 2011:109\u201316."},{"key":"2025082701124557000_16.3.e252602.16","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H686"},{"key":"2025082701124557000_16.3.e252602.17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7237.768"},{"key":"2025082701124557000_16.3.e252602.18","unstructured":"Asthma and Allergy Foundation of America . Latex Allergy [Internet] Virginia: www.aafa.org. 2022. Available: www.aafa.org\/latex-allergy\/"},{"key":"2025082701124557000_16.3.e252602.19","unstructured":"Bnf.nice.org.uk . Protamine sulfate | Drugs. [Internet] National Institute for Health and Care Excellence. 2022. Available: https:\/\/bnf.nice.org.uk\/drug\/protamine-sulfate.html"},{"key":"2025082701124557000_16.3.e252602.20","unstructured":"Medicines.org.uk . Toctino 10mg soft capsules[Internet]. Summary of Product Characteristics (SmPC) - (emc). 2021. Available: www.medicines.org.uk\/emc\/product\/6364\/smpc#gref"},{"key":"2025082701124557000_16.3.e252602.21","unstructured":"European Medicines Agency (EMA) . Medicinal products for human use; safety, environment and information; excipients in the label and package leaflet of medicinal products for human use, volume 3B. [internet]. 2003. Available: www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003412.pdf"},{"key":"2025082701124557000_16.3.e252602.22","unstructured":"NHS medicines A to Z: peppermint oil[internet]. NHS.uk. 2022. Available: www.nhs.uk\/medicines\/peppermint-oil\/"},{"key":"2025082701124557000_16.3.e252602.23","unstructured":"Medicines and Healthcare Products Regulatory Agency . Additional warning statements for inclusion on the label and\/or in the leaflet of certain medicines. Pp.4 [Internet]. 2019. Available: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/835489\/Warning_Statements.pdf"},{"key":"2025082701124557000_16.3.e252602.24","unstructured":"South West Yorkshire Area Prescribing Committee . Medicines safety sub-group. medicines safety bulletin [internet]. 2019. Available: www.swyapc.org\/wp-content\/uploads\/2019\/08\/Peanut-Allergy-Bulletin-FINAL.pdf"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2022-252602","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:12:58Z","timestamp":1756282378000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2022-252602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3,14]]},"published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1136\/bcr-2022-252602"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2022-252602","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}